Department of Pathology, Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital, Chicago, Illinois; Members of the Cytopathology Milestones 2.0 Workgroup.
Department of Pathology, University of Vermont Medical Center, Vermont; Members of the Cytopathology Milestones 2.0 Workgroup.
J Am Soc Cytopathol. 2021 Sep-Oct;10(5):485-494. doi: 10.1016/j.jasc.2021.04.003. Epub 2021 May 24.
Primary stakeholders in the Accreditation Council for Graduate Medical Education (ACGME) Milestones Project are: ACGME, Residency Programs, Residents, Fellowship Programs, Fellows, and Certification Boards. The intent of the Milestones is to describe the educational and professional developmental trajectory of a trainee from the first stages of their postgraduate education through the completion of their clinical training. The Milestones 2.0 project includes changes made based on experience with Milestones 1.0.
The ACGME solicited volunteers to participate in the development of subspecialty Milestones 2.0. The workgroup was charged with reviewing/making any additions to the four "Harmonized Milestones", developing subspecialty specific milestones for the Patient Care and Medical Knowledge competencies, and creating a supplemental guide. The Milestones were finalized following review of input from an open comment period.
The Cytopathology Milestones 2.0 will go into effect July 2021. They include additional subcompetencies in the 4 harmonized competency areas and cytopathology-specific edits to the patient care and medical knowledge subcompetencies. Although the number of subcompetencies has increased from 18 to 21, within each subcompetency, the number of milestone trajectories has decreased. Additionally, within each subcompetency, the wording has been streamlined. A supplemental guide was created and Milestones 1.0 were compared to 2.0; however, curriculum mapping has been left to programs to develop.
The ultimate goal of the Cytopathology Milestones 2.0 is to provide better real-time documentation of the progress of cytopathology fellows. The expected outcome is to produce highly competent cytopathologists, improving the care they provide, regardless of the program at which they trained.
研究生医学教育认证委员会（ACGME）里程碑项目的主要利益相关者包括：ACGME、住院医师培训计划、住院医师、专科医师培训计划、专科医师和认证委员会。里程碑的目的是描述从研究生教育的早期阶段到临床培训完成期间学员的教育和专业发展轨迹。里程碑 2.0 项目包括根据里程碑 1.0 的经验进行的更改。
ACGME 征求志愿者参与专科里程碑 2.0 的制定。工作组的任务是审查/添加四个“协调里程碑”、为患者护理和医学知识能力开发专科特定的里程碑，并创建补充指南。在对公开意见征询期的反馈进行审查后，最终确定了里程碑。
细胞病理学里程碑 2.0 将在 2021 年 7 月生效。它们包括在四个协调能力领域增加额外的子能力，以及对患者护理和医学知识子能力进行细胞病理学特定的编辑。虽然子能力的数量从 18 个增加到 21 个，但在每个子能力中，里程碑轨迹的数量减少了。此外，在每个子能力中，措辞也更加简洁。创建了一个补充指南，并将里程碑 1.0 与 2.0 进行了比较；然而，课程映射仍由各计划自行开发。
细胞病理学里程碑 2.0 的最终目标是提供更好的实时记录细胞病理学家的进展情况。预期的结果是培养出高度合格的细胞病理学家，提高他们提供的护理质量，而不论他们接受培训的计划如何。
